252 related articles for article (PubMed ID: 2881797)
1. Occurrence of calcitonin, somatostatin-like immunoreactivity, and carcinoembryonic antigen in two sisters suffering from familial thyroid medullary carcinoma.
Bethge N; Ahuja S; Diel F
Exp Clin Endocrinol; 1986 Dec; 88(3):365-72. PubMed ID: 2881797
[TBL] [Abstract][Full Text] [Related]
2. Familial and sporadic medullary thyroid carcinoma: clinical and immunohistological findings.
Ekblom M; Välimäki M; Pelkonen R; Jansson R; Sivula A; Franssila K
Q J Med; 1987 Nov; 65(247):899-910. PubMed ID: 2901773
[TBL] [Abstract][Full Text] [Related]
3. Plasma and tumor levels of somatostatin (SRIF) and somatostatin immunochemistry in medullary thyroid carcinoma: apparently discrepant preliminary results.
Franc B; Chayvialle JA; Modigliani E; Calmettes C; Caillou B; Dutrieux-Berger N; Houdent C; Kujas M
Henry Ford Hosp Med J; 1987; 35(2-3):147-8. PubMed ID: 2891647
[No Abstract] [Full Text] [Related]
4. [Immunohistochemical detection of calcitonin, ACTH, beta-MSH, beta-endorphin and somatostatin in medullary carcinoma of the thyroid. Immunoperoxidase study (PAP, ABC) of 10 cases].
Charpin C; Argemi B; Cannoni M; Oliver C; Gillioz P; Vagneur JP; Toga M
Ann Pathol; 1984; 4(1):27-35. PubMed ID: 6142718
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen and calcitonin as markers of malignancy in medullary thyroid carcinoma.
Cox CE; VanVickle J; Froome LC; Mendelsohn G; Baylin SB; Wells SA
Surg Forum; 1979; 30():120-1. PubMed ID: 395674
[No Abstract] [Full Text] [Related]
6. Immunohistochemical hormone content in medullary and undifferentiated thyroid carcinoma and prognosis after surgery.
Henninger S; Schatz H; Stracke H; Wagner U; Kracht J
Acta Histochem; 1988; 83(1):51-6. PubMed ID: 2897752
[TBL] [Abstract][Full Text] [Related]
7. Tumor and plasma somatostatin-like immunoreactivity in transplantable rat medullary thyroid carcinoma.
Birnbaum RS; Muszynski M; Roos BA
Cancer Res; 1980 Nov; 40(11):4192-6. PubMed ID: 6110476
[TBL] [Abstract][Full Text] [Related]
8. Somatostatin-immunoreactive cells in medullary carcinoma of the thyroid.
Sundler F; Alumets J; Håkanson R; Björklund L; Ljungberg O
Am J Pathol; 1977 Aug; 88(2):381-6. PubMed ID: 195473
[TBL] [Abstract][Full Text] [Related]
9. [Screening for the familial form of medullary cancer of the thyroid].
Allannic H
Bull Cancer; 1984; 71(2):125-9. PubMed ID: 6733292
[TBL] [Abstract][Full Text] [Related]
10. [Medullary carcinoma of the thyroid gland. Clinico-pathologic and immunohistochemical study].
Elsner B; De Marco L; López S; Curutchet HP
Medicina (B Aires); 1983; 43(3):263-70. PubMed ID: 6369069
[No Abstract] [Full Text] [Related]
11. [Plasma tumor markers (calcitonin and carcinoembryonic antigen) in medullary thyroid cancers].
Argémi B; Vagneur JP; Conforto C; Even F; Rollat MC; Simonin R
Bull Cancer; 1984; 71(2):133-9. PubMed ID: 6733293
[TBL] [Abstract][Full Text] [Related]
12. Immunoreactive gastrin-releasing peptide in medullary thyroid carcinoma.
Modigliani E; Casanova S; Chayvialle JA; Bernard C; Franc B; Cohen R; Calmettes C
J Clin Endocrinol Metab; 1990 Oct; 71(4):831-5. PubMed ID: 1976126
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of calcitonin and carcinoembryonic antigen (CEA) in medullary carcinoma of the thyroid (MCT) by immunoperoxidase technique.
Talerman A; Lindeman J; Kievit-Tyson PA; Dröge-Droppert C
Histopathology; 1979 Nov; 3(6):503-10. PubMed ID: 389771
[TBL] [Abstract][Full Text] [Related]
14. Calcitonin, somatostatin and ACTH immunoreactive cells in a case of familial bilateral thyroid medullary carcinoma.
Charpin C; Andrac L; Monier-Faugere MC; Hassoun J; Cannoni M; Vagneur JP; Toga M
Cancer; 1982 Nov; 50(9):1806-14. PubMed ID: 6126268
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of the precancer state in hereditary medullary thyroid carcinoma].
Takami H; Shikata J; Kakudo K; Yashiro T; Ito K
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1657-61. PubMed ID: 2730063
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical and serological demonstration of thyreoglobulin tissue polypeptide antigen, carcinoembryonic antigen and calcitonin in diversely differentiated thyroid gland carcinomas and thyroid gland adenomas].
Vogel J; Oehr P; Grouls V
Pathologe; 1985 May; 6(3):133-40. PubMed ID: 3892526
[No Abstract] [Full Text] [Related]
17. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of somatostatin-immunoreactivity in an adrenal pheochromocytoma and a thyroid medullary carcinoma (Sipple syndrome).
Bethge N; Ahuja S; Diel F; Usadel KH
Exp Clin Endocrinol; 1988 May; 91(2):217-22. PubMed ID: 2900771
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic values of the doubling time of serum carcinoembryonic antigen and calcitonin levels in medullary thyroid carcinoma].
Miyauchi A; Onishi T; Matsuzuka F; Hirai K; Kuma K; Takai S; Nakamoto K; Nakamura K; Nanjo S; Maeda M
Gan No Rinsho; 1986 Oct; 32(12):1519-24. PubMed ID: 3783976
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of continuous cell line MTC-SK derived from a human medullary thyroid carcinoma.
Pfragner R; Höfler H; Behmel A; Ingolic E; Walser V
Cancer Res; 1990 Jul; 50(13):4160-6. PubMed ID: 1972348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
